Taken together, our findings show that reductions in apoB should be the primary goal of lipid lowering, because not only does this lead to lower risk of common diseases such as heart disease and stroke, but also a reduction in apoB prolongs life by a period of months to years. The gene discussed is APOB; the disease is heart disorder.